Associacao Fundo de Incentivo a Psicofarmcologia   Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Sao Paulo Brazil (1976)

Organization Overview

First Clinical Trial
1999
NCT00480870
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

donepezil (aricept) (2 trials)

zolpidem (ambien) (1 trial)

Drugs in Phase 3 Trials (2)

fatty acid (1 trial)

naltrexone (revia) (1 trial)

Drugs in Other Trials (3)

azelaic acid (azelex) (1 trial)

drospirenone (Yasmin) (1 trial)

ethinyl estradiol (Estinyl) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Alcoholism (Phase 3)

Alzheimer Disease (Phase 4)

Apnea (Phase 4)

Sleep Apnea, Obstructive (Phase 4)

Sleep Apnea Syndromes (Phase 4)

Sleep Initiation and Maintenance Disorders (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 7